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Abstract 
Objectives 
This study aimed to investigate whether measures of cardiopulmonary fitness and relative 
exercise intensity were associated with high sensitivity cardiac troponin T (cTnT) rise after a 
road marathon. 
Methods 
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Fifty-two marathon runners (age 39±11yrs, body mass 76.2±12.9kg, height 1.74±0.09m) 
attended the laboratory between 2 and 3 weeks prior to attempting the Brighton Marathon, 
UK. Running economy at 10km.hr-1 (RE10) and race pace (RERP), ventilatory threshold 
(VT) and VO2max tests were completed. CTnT was measured within 48 hours prior to the 
marathon and within 10 mins of completing the marathon, using a high sensitivity assay. 
Heart rates (HR) were recorded throughout the marathon. 
 
Results 
Runners demonstrated a significant increase in cTnT over the marathon (pre-race 
5.60±3.27ng.L-1, post-race 74.52±30.39ng.L-1, p<0.001). Markers of endurance performance 
such as running economy (10km.hr-1 223±18ml.kg-1.km-1; race pace 225±22ml.kg-1.km-1), VT 
(38.5±6.4ml.kg-1.min-1) and V̇O2max (50.9±7.7ml.kg-1.min-1) were not associated with post-
race cTnT. Runners exercise intensity correlated with post-race cTnT (Mean HR %VT 
104±5%, r=0.50; Peak HR %VT 118±8%, r=0.68; Peak HR %V̇O2max 96±6, r=0.60, p<0.05) 
and was different between the low, medium and high cTnT groups (p<0.05).  
 
Conclusions 
CTnT increases above reference limits during a marathon. Magnitude of cTnT rise is related 
to exercise intensity relative to ventilatory threshold and V̇O2max, but not individuals’ 
absolute cardiopulmonary fitness, training state or running history.  
 
Keywords: Heart, Endurance, Stress, Cardiopulmonary fitness, Running. 
 
Introduction 
With the growing number of people participating in mass endurance events1 there is an 
increasing need to understand the impact of undertaking such activity on cardiac health 2. 
Cardiac troponin (cTn) is a biomarker released from the myocardium during periods of 
cardiac stress and injury 3. Cardiac troponin T rises above clinically significant values 
(typically levels greater the 99th percentile of a healthy reference population) after marathon 
running 4–7. Some work has shown marathon times 4,8,9, marathons completed 10, training 
status 11,12, body mass 13 and age 8,10 to be associated with cardiac troponin rise, yet 
research on causes of this rise are equivocal.  
Shave et al 13 demonstrated, within a meta-analysis, that cTn values were lower in longer 
duration endurance events, propounding the importance of exercise intensity in endurance 
activities. Studies have since attempted to evaluate the influence of exercise intensity during 
endurance running, showing elevated cTnI with higher intensity work when setting relative 
intensity 14 or competition intensity 15 over fixed durations of 180mins. Legaz-Arrese et al 15 
went on to imply that there may be a critical exercise intensity or threshold at which cTn rise 
occurs. More recently, Eijsvogels et al 16 demonstrated a positive correlation (r=0.752) 
between exercise intensity and cTnl rise using groups of walkers and runners. Most previous 
work has either fixed the intensity and duration 14,15, or used completion time and heart rate 
as a percentage of age predicted maximum 8 as a means of quantifying intensity. In contrast, 
when measuring cardiopulmonary fitness, Trivax et al 17 found no association between 
maximal oxygen uptake (V̇O2max) markers and the release of cTnl. While Wilhelm et al 6 did 
not report any relationship between training state, V̇O2max and cTnT. However, there still 
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appears to be limited evaluation of cardiopulmonary fitness markers measured prior to 
marathon running as a means of quantifying relative work intensity during a competitive 
marathon and relating that to cTnT rise. Much of this previous work has used lower 
sensitivity cTnT analysis methods or measurement of cTnI. Measurement using high 
sensitivity cTnT analysis now allows improved accuracy, detection and identification of those 
above reference limits 18. 
Based on prior findings, it was hypothesised that relative exercise intensity derived from 
markers of endurance performance would be related to cTnT rise in amateur runners during 
a competitive road marathon. 
 
Method 
Fifty-two runners (13 females, 39 males) aged 39±11yrs (mean±SD), body mass 
76.2±12.9kg, height 1.74±0.09m, completed all tests and finished the Brighton marathon (9th 
April 2017). The study was advertised by email and social media to those who had entered 
the Brighton marathon, runners then volunteered to take part in the study. Runners provided 
written informed consent and institutional ethical approval (SSCERC 0217) was issued by 
the University of Brighton in accordance with the Helsinki declaration 1975 (revised 2013). 
Thirty-four of the runners had previously completed a marathon. The average number of 
previous marathons was 3±6 (range 0 to 30). Participants self-reported 3 month training 
history prior to the marathon was 32.5±13.8miles per week (range 10 to 80miles per week) 
at an average pace of 11.4±1.7km.hr-1 (range 7 to 15km.hr-1).  
All exercise tests were conducted either 2 or 3 weeks prior to the marathon. Runners were 
required to complete a run at 10km.hr-1 for 5 mins (RE10) and a ‘race pace’ run for a further 
5 mins (RERP) to obtain running economy at the different paces. Runners rested for 10 mins 
and then completed an incremental ventilatory threshold (VT) and maximal oxygen uptake 
test (V̇O2max). ‘Race pace’ was estimated from participants self-reported expected pacing, 
training pace or expected finishing time. 
On the two days prior to the marathon, runners were invited to give a resting venous blood 
sample and complete a training diary. Participants were advised not to undertake any 
strenuous activity between the pre-race blood sample and the marathon. On the morning of 
the marathon participants were given a heart rate (HR) monitor to collect heart rate 
throughout the race. Immediately after the marathon participants were escorted to the 
medical tent, 80m after the finish line, to give a venous blood sample. Weather conditions 
over the day of the marathon were unusually hot and sunny for the UK in April (18-23°C, 40-
50%RH). 
Runners completed a run on a treadmill at 10km.hr-1, 1% gradient, for 5 mins (RE10) and a 
‘race pace’ run, on 1% gradient, for a further 5 mins (RERP). ‘Race pace’ was determined by 
the runners’ personal target time for the marathon and training information (11.2±1.9km.hr-1, 
range 7.1 to 15.3km.hr-1). Breath by breath expired gas (Metamax 3B, Cortex, Germany) 
and HR (Polar A300, Kempele, Finland) was collected throughout. RE10 and RERP were 
calculated from the average physiological values for the final 30 sec of each stage.  
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A VT and V̇O2max test was completed 10 minutes after the RE10 and RERP test. Starting 
velocities and increments were determined by the runners training status and RERP, to 
achieve a test which lasted between 8 and 12 mins. Breath by breath expired gas and heart 
rate was collected throughout using the same equipment as the prior RE10 and RERP tests. 
Rating of perceived exertion (RPE) was collected immediately upon test completion. VT was 
determined using 9 panel plots and the v-slope method by two independent researchers 19. 
V̇O2max was determined if two of the following three criteria were achieved: a V̇O2 plateau 
(within 0.2ml.kg-1.min-1) between two incremental stages, an RPE of ≥19 and a heart rate 
within 8bts.min-1 of age predicted maximum (220 - age). All runners achieved this V̇O2max 
criteria. 
Twenty-five runners chose to wear their own personal recording HR monitor (various models 
of Polar or Garmin, all beat-to-beat), checked by the research team. The remaining twenty-
seven runners were given a Polar A300 (Kempele, Finland) to wear throughout the race. Of 
the 52 participants, 38(74%) recorded full HR traces, these were downloaded and the time 
that HR was above VT was analysed. From the 14(26%) monitors that were not capable of 
downloading, mean and peak HR was obtained directly from the watch. From the files 
downloaded, peak HR was taken as the highest HR maintained for at least 1 minute during 
the marathon.  
Runners gave a resting pre-race venous blood sample on either of the two days prior to the 
marathon. Post-race blood samples were taken within 5 min of runners completing the race 
by escorting the runners into the medical tent (80m after finish line). For both pre and post-
race samples, 5ml of blood was extracted from the antecubital vein. Whole blood was then 
stored in Gel (SST gel) BD vacutainers and analysed within 4 hours of collection. CTnT was 
analysed using an electrochemiluminescence assay [Roche Modular E170 (fifth generation); 
Basel, Switzerland] 18. This had a limit of blank of 3ng.L-1, limit of detection (LoD) of 5ng.L-1, 
upper reference limit (URL) based on the 99th percentile of 14ng.L-1, coefficient of variation at 
URL of <8%.   
Data was assessed for normality and sphericity and adjusted where necessary using the 
Huynh-Feldt method. Paired t-tests were used to calculate difference in pre to post race 
cTnT values. Both Pearson’s and Spearman correlation were used where appropriate to 
determine relationship between cardiopulmonary fitness measures, exercise intensity and 
cTnT change on the whole sample. Additionally, the data set was split into three groups 
based on absolute post-race cTnT values; lowest third (LcTnT n=18), middle third (McTnT, 
n=16) and highest third (HcTnT, n=18). Group differences were analysed using ANCOVA, 
Bonferroni post hoc analysis compared separate groups. All statistical tests were completed 
using SPSS Statistics 22 (IBM, New York). Significance was accepted at p<0.05. Values are 
reported as mean±SD unless otherwise indicated. 
 
Results 
Pre-race, thirty-four participants presented with values below the LoD (5ng.L-1), two 
participants presented with values above the URL (14ng.L-1).  CTnT and exercise testing 
data is shown in Table 1. Pre to post race cTnT increased by 68.92±30.16ng.L-1 over the 
marathon (p<0.001). All fifty-two runners presented post-race with cTnT values above the 
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URL. There was no difference in post-race cTnT between gender groups. The three cTnT 
groups were not different pre-race, but were by the end of the race (p<0.001, Table 1). 
There was no association between post-race cTnT and self-reported training history [prior 3 
month training volume (r=-0.02) or average training pace (r=0.05)].  
Measures taken during RE10 and RERP were not found to be associated with cTnT rise, nor 
were running economy values different between LcTnT or HcTnT groups. RERP was similar 
to individual’s calculated velocity at VT (Velocity RERP 11.0±1.8%; Velocity VT 11.1±1.9%, 
r=0.89, p<0.01). Subsequently HR at RERP was 101.1±6.9% of VT (r=0.83, p<0.01).  
No absolute measures of VT or V̇O2max were related to cTnT rise. VT variables expressed 
as a percentage of V̇O2max (Velocity 68±5%; V̇O2 76± 8%; HR 84±4%) were also not 
associated with cTnT. cTnT groups were not different for any markers of cardiopulmonary 
fitness.  
Runners completed the marathon in 262±52mins (range 166 to 380mins) at a mean velocity 
of 10.1±2.4km.hr-1. This was 23±26mins slower than what runners expected to achieve 
based on self-reported race pace. VT based prediction of race time (235±45mins) was also 
on average 26±31mins faster than what runners achieved. Overall marathon time was not 
associated with cTnT rise, nor was the difference between expected and achieved time.  
Mean HR during the marathon (157±14bts.min-1) was 102±5% of that performed at VT 
(154±13bts.min-1) during exercise testing and correlated strongly (r=0.87, p<0.01). Yet 
average velocity was slower during the marathon (Marathon 10.1±1.9 km.hr-1; VT 11.1±1.9 
km.hr-1). Mean HR was 86±4% of max HR achieved at V̇O2max and 87±5% of age predicted 
HR max. Peak HR during the marathon (178±14bts.min-1) was 115±8% of that performed at 
VT (r=0.68, p<0.01), 97±7% of max HR achieved at V̇O2max and 98±6% of age predicted 
HR max.  
Both mean HR (r=0.50, p<0.05) and peak HR (r=0.68, p<0.01) expressed as a percentage of 
VT were found to be strong correlates of post-race cTnT (Figure 1). Additionally, both 
variables were greater in the HcTnT group (p<0.05) (Table 1). Total time spent above VT 
was weakly correlated with post-race cTnT (r=0.28, p<0.05). Peak HR expressed as a 
percentage of max HR achieved during V̇O2max was also strongly associated with cTnT 
(r=0.60, p<0.01) and was greater in the HcTnT group (p<0.05) compared to both LcTnT and 
McTnT groups.  
 
Discussion 
The study measured markers of endurance performance and cTnT in fifty-two runners 
undertaking the Brighton marathon. The findings demonstrated that post-race cTnT is 
associated with working at a greater relative exercise intensity during the marathon. Further, 
post-race cTnT rise was not associated with any absolute markers of cardiopulmonary 
fitness, endurance performance, marathon time or prior experience and training.  
Comparison of absolute cTn values to others work must consider sensitivity improvements in 
cTn analysis and thus expect a less dynamic range. There are excellent reviews available on 
marathon running and cTn rise 5,13, however these were written prior to analytical 
developments. To our knowledge only a small number of papers have used fifth generation 
cTnT assay analysis post marathon 4,6,7. Work by Scherr et al 7, noted slightly lower values 
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[31.07 (IQR 19.25 - 46.86) ng.L-1] of post-race cTnT. While Roca et al 4, shows similar [46.9 
(IQR 24.1 -  91.1)ng.L-1] cTnT rise to that seen in the current study [50.12 (IQR 28.3 -  
67.9)ng.L-1].  
The potentially damaging effects of excessive endurance exercise on the heart are well 
discussed elsewhere 20. The measurement of cTnT related to these deleterious effects and 
the clinical significance of raised cTnT values has yet to be established. Wilhelm et al 6 
evaluated structural and functional cardiac assessment in response to a marathon in 
combination with cTnT (fifth generation) measurements. Wilhem et al 6 and others 7,21 
suggest short duration cTn release seems to be as a result of membrane leakage induced 
by altered myocyte metabolism, as opposed to permanent cardiomyocyte necrosis. Our 
study only evaluated the biomarker cTnT and not the underlying inflammatory mechanisms. 
Work by others 6,7,22,23 offer greater explanation for the cardiac stress, whether this is in 
response to exercise induced inflammatory processes is equivocal.  
Relative exercise intensity during the marathon was found to induce rise in cTnT. The 
findings support the previous work of others 14,15 who used fixed duration and intensity trials 
to demonstrate that greater intensity, long duration (180min) exercise induces rise in cTn. 
This work builds upon the fixed nature of these trials to demonstrate this response in a 
competitive ‘self-paced’ marathon. Eijsvogels group 8,16,24 has produced much work 
attempting to evaluate the role of exercise intensity in self-paced long duration exercise. To 
demonstrate this relationship across a wide intensity range Eijsvogels et al 24 used groups of 
twenty-three walkers and runners, completing 40.6-42km, to show strong correlation 
between %HRmax and cTnI (r=0.752, p<0.001). Later 16, Eijsvogels found no association 
between exercise intensity and cTnI in ninety-two competitive marathon runners. Age 
predicted HRmax attained (91±5%) suggested similar exercise intensities between runners, 
which authors used to explain why longer duration rather than higher intensity exercise 
correlated with cTnI. Our group showed slightly higher age predicted HRmax values 
(98.5±6.4%) during the marathon, with only a weak correlation (r=0.3) to cTnT. Using a 
similar method, Scherr et al 7 found no relationship between mean exercise intensity 
(%HRmax), finishing time, training history and cTnT rise. In the only other study to measure 
cardiopulmonary fitness markers and HR during a marathon, Trivax et al 17 found no 
association between variables at V̇O2max and cTnI rise. However, the lack of analytical 
comparison between cardiopulmonary fitness measures and HR recorded during the race, in 
addition to the reduced sensitivity of the cTnI assay and small sample size (n=25), possibly 
prevented similar findings to that presented here. Many of the studies above have used peak 
HR attained against age predicted HRmax, however this is unlikely to provide an effective 
spread of data to identify reasons for those with elevated cTn. More importantly, it is not an 
accurate representation of, or relative to, the individual’s physiological thresholds and limits. 
When using peak HR attained in the marathon against HR achieved at V̇O2max (r=0.60) or 
at VT (r=0.68), our work showed much stronger correlation with cTnT values, than when 
using age predicted max (r=0.3).  
In shorter duration activity, Fu et al 25 showed that cTnT was significantly elevated when 
running at 100%VT in comparison to 80%VT for both 45 and 90 min trials. Authors 25 
concluded that duration and intensity were important to cTnT rise, but intensity induced a 
more pronounced increase. Other work, has looked at higher intensity intermittent exercise 
with various results. Carranza-Garcia et al 26 showed no increase in cTnT after heavy 
resistance training or a football match. Yet in a smaller study Nie et al 27 demonstrated 
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increases in cTnT and cTnl in adolescent basketball players. Clearly further consideration of 
cTnT and sustained exercise intensity activity is warranted. 
Unlike work by others 4,8,9, exercise duration was not related to cTnT in this study. As 
mentioned by Eijsvogels et al 16 the relationship between duration and intensity is difficult to 
derive and in some instances should be viewed as a ‘load’. Otherwise the study design 
should either fix intensity or duration, as approached by the Legaz-Arresse and Serrano-
Ostariz group 14,15.  Jassal et al 9 demonstrated that cTnT increase was greater (r=0.40) with 
exercise time. However, this was collated using both half and full marathons and a large 
proportion of runners had no detectable cTnT rise. In our study design the measurement of 
prior cardiopulmonary fitness parameters to derive relative values and sensitivity of cTnT 
allows clearer interpretation. 
The HcTnT group presented a significantly lower HR at VT during exercise testing, yet 
velocity and V̇O2 at VT were the same for both groups (Table 1). This means there is a 
greater oxygen pulse (ml.bt-1) at VT in the HcTnT group, indicating a greater stroke volume 
during submaximal activity. However, there were no differences seen by V̇O2max, nor were 
there differences in absolute HR requirements during the race. It is therefore possible that 
individuals more reliant on greater stroke volume to maintain cardiac output induce 
potentially greater cardiac strain, which over long duration endurance activity is not 
sustainable, especially exacerbated by potential dehydration and declining venous return. 
This could subsequently induce greater cardiomyocyte membrane leakage. This links to the 
work by Feng et al 28 whom demonstrated a relationship between left ventricular end 
diastolic pressure and cTnl rise. While McNeil et al 29 showed greater mechanical stretch in 
skeletal muscle caused cell wounds and troponin leakage. These preliminary findings here 
justify further research. 
No marathon performance, cardiopulmonary fitness or running economy measures were 
associated with cTnT, which is supported by most prior work 6,8,17. Velocity during the 
marathon (10.1±1.8km.hr-1) was slower than both the RERP (11.0±1.8km.hr-1) and velocity 
at VT (11.1±1.9km.hr-1). The similarity between RERP and VT demonstrates individuals 
were not able to pace at their expected velocity for the whole race. It appears as though this 
is related to experience and training as the difference in actual and expected time was 
associated with previous marathon number (r=0.52) and marathon time (r=0.55) but no 
physiological or performance variables. Other work10–12 using training reports or running 
history, have suggested training status to be a factor, yet in our work self-reported training 
pace (r=0.05) or training volume (r=-0.02) showed no association with cTnT. Clearly, self-
reported methods have limitations but these findings would corroborate that cTn rise cannot 
be predicted by an individual’s prior fitness, experience, training or economy. 
One limitation is that cTnT values were taken immediately after the race. However, this is not 
necessarily reflective of the peak cTnT occurring, others work has shown values to peak at 
various times during and post marathon 21, although a peak is likely to be seen within the 3 
hours post-race 30. 
In the current study mean and peak heart rates were analysed throughout the marathon, 
while time spent above VT was also assessed on the full HR data sets. However, time above 
VT may have greater association to cTnT rise than reported here due to sporadic drop out of 
HR telemetry data and therefore accuracy of time analysis. Further, peak heart rate during 
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the race may be caused by a number of external factors such as crowd involvement. 
Therefore taking too much from these parameters could be potentially onerous.  
Conclusion 
This is the first study to demonstrate that road marathon exercise intensity relative to VT and 
V̇O2max is associated with elevated high sensitivity cTnT. Data suggests that exercising at 
an average heart rate above that of VT or alternatively, achieving a peak HR at a higher 
percentage of VT or V̇O2max may induce greater rise in cTnT. The physiological and clinical 
relevance of this requires elucidation. Future work should consider evaluation of sub-clinical 
pathology and risk factors of a cardiovascular event.  
Practical Implications 
 During marathon running the heart undergoes stress that releases a protein called 
troponin T.  
 Those that work at a harder intensity during the marathon, relative to their overall 
cardiopulmonary fitness, tend to see greater increases in troponin T. 
 Marathon runners may consider utilising cardiopulmonary exercising as a means of 
using relative exercise intensity to pace a race. 
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Figure 1: Marathon mean and peak heart rates as a percentage of ventilatory threshold (VT) 
against post-race high sensitivity cardiac troponin T (cTnT). A: Mean heart rate (r2=0.246, 
y=3.2541x-281.04). B: Peak heart rate (r2=0.467, y=2.608x-246.15). 
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Table 1: Performance measures correlated to post-race cardiac troponin T and comparison 
of low, medium and high cardiac troponin T groups.  
Table 1: Performance measures correlated to post-race cardiac troponin T and comparison 
of cardiac troponin T groups.  
* denotes significant correlation with post-race cTnT for whole sample. # denotes significant 
difference between HcTnT and LcTnT groups. ‡ denotes significant difference between 
McTnT and HcTnT. † denotes significant difference between LcTnT and McTnT. Running 
economy at 10km.hr-1 (RE10), Running economy at chosen race pace (RERP), Ventilatory 
Threshold (VT), Heart rate (HR), High sensitivity cardiac troponin T (cTnT), Low cardiac 
troponin T group (LcTnT), High cardiac troponin T group (HcTnT).  
 
Overall 
(n = 52) 
Mean  SD 
Correlation with 
Post-Race cTnT 
(r / p) 
LcTnT Group 
(n = 18) 
Mean  SD 
McTnT Group 
(n = 16) 
Mean  SD 
HcTnT Group 
(n = 18) 
Mean  SD 
Age (yrs) 39  11 -0.06 / 0.68 40  10 
40  14 
37  9 
Height (m) 1.74  0.09 0.13 / 0.37 1.72  0.08  
1.72  0.09 ‡ 
1.78  0.08 # 
Weight (kg) 76.2  12.9 0.09 / .55 75.0  14.0 74.2  15.8 79.0  9.0 
VO2 @ RE10 (ml.kg-1.km-1) 228  18 0.04 / 0.81 224  19 
228  18 
225  18 
Velocity @ RERP (km.hr-1) 11.0  1.8 -0.13 / 0.36 10.8  1.7 
10.6  2.4 
10.8  1.6 
VO2 @ RERP (ml.kg-1.km-1) 225  22 0.04 / 0.75 224  24 
231  21 
221  21 
Velocity @ VT (km.hr-1) 11.1  1.9 -0.17 / 0.23 11.2  1.7 
10.5  2.3 
11.0  1.8 
VO2 @ VT (ml.kg-1.min-1) 38.7  6.4 -0.08 / 0.56 37.7  6.9 
37.8  7.5 
37.9  5.6 
HR @ VT (bts.min-1) 155  14 0.27 / 0.053 161  14 
158  15 
152  12 # 
Velocity @ VO2max (km.hr-1) 16.2  2.6 -0.08 / 0.58 16.0  2.3 
15.4  3.3 
16.0  2.4 
VO2 @ VO2max (ml.kg-1.min-1) 50.8  7.7 -0.09 / 0.53 49.9  8.0 
49.8  9.1 
50.1  6.9 
HR @ VO2max (bts.min-1) 184  15 -0.18 / 0.21 189  17 
185  17 
181  13 
Marathon Time (mins) 265  52 0.04 / 0.79 263  45 
273  66 
259  48 
Marathon Mean HR (bts.min-1) 160  14 -0.02 / 0.88 162  14 
158  18 
160  12 
Marathon Mean HR (% VT) 101.7  4.6 0.50 / 0.001 * 100.3  4.0 100.4  4.3 ‡ 105.0  3.5 # 
Marathon Mean HR (%VO2max) 86.4  4.2 0.26 / 0.064 85.7  4.1 
85.7  4.7 
88.1  3.4 
Marathon Mean HR 
(% Age Predicted Max) 
88.4  5.3 -0.09 / 0.54 90.0  5.1 88.0  6.4 87.3  4.5 
Marathon Time HR > VT (mins) 235  43 (n=38) 0.28 / 0.045 *  230  37 (n=13) 235  49 (n=11) 238  47 (n=14) 
Marathon Peak HR (bts.min-1) 178  14 0.28 / 0.045 * 177  13 
175  18 
181  11 
Marathon Peak HR (% VT) 113.6  8.0 0.68 / 0.001 * 110.1  5.6 
111  6.8 ‡ 
119.7  7.5 # 
Marathon Peak HR (%VO2max) 96.4  6.0 0.60 / 0.001 * 94.0  5.0 
94.7  5.2 ‡ 
100.4  5.8 # 
Marathon Peak HR 
(% Age Predicted Max) 
98.5  6.4 0.30 / 0.029 * 98.7  5.4 97.2  7.6 99.5  6.5 
cTnT pre-race (ng.L-1) 5.60  3.27 0.12 / 0.41 4.43  1.89 
5.78  3.89 
5.65  3.85 
cTnT post-race (ng.L-1) 74.52  30.39 - 22.83  6.03 † 42.93  6.20 ‡ 84.94  23.14 # AC
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